CAS: 2050478-92-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Cetrelimab REF: TM-T76945CAS: 2050478-92-5 | >95% | 203.00 €~1,617.00 € | Thu 24 Apr 25 |
 | Cetrelimab REF: 3D-CLA1518CAS: 2050478-92-5 | - - - | To inquire | Tue 06 May 25 |
Cetrelimab
CAS:2050478-92-5
Cetrelimab (JNJ 63723283) is a humanized monoclonal antibody targeting PD-1, useful in research on multiple …
Purity:
>95%
Color and Shape:
Liquid
Ref: TM-T76945
| 1mg | 203.00 € | ||
| 5mg | 523.00 € | ||
| 10mg | 838.00 € | ||
| 25mg | 1,245.00 € | ||
| 50mg | 1,617.00 € |
Estimated delivery in United States, on Thursday 24 Apr 2025
Cetrelimab
CAS:2050478-92-5
An anti-human IgG4 kappa, anti-programmed cell death protein-1 (PD-1) antibody.
Ref: 3D-CLA1518
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 6 May 2025
